# Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers

> **NCT02385123** · PHASE4 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 60 (actual)

## Conditions studied

- Influenza
- Influenza Immunisation

## Interventions

- **BIOLOGICAL:** Influenza Virus Vaccine Inactivated

## Key facts

- **NCT ID:** NCT02385123
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04-01
- **Primary completion:** 2019-12-06
- **Final completion:** 2020-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Why stopped:** Study was terminated due to COVID-19 pandemic.
- **Last updated:** 2023-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02385123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02385123, "Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02385123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*